Open original FDA record ↗Recall record
- FDA identifier
- Z-1825-2012
- Company in FDA record
- App Pharmaceuticals Llc
- FDA classification date
- Jun 19, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
CGMP Deviations: Incomplete documentation associated with test results.
Source facts
- Action
- APP sent an URGENT DRUG RECALL LETTER and Response Form dated May 20, 2010, to all affected consignees. The consignees contacted were at the retail/ medical facilities/hospital IeveIs, including intermediate wholesale IeveIs. Direct distributor consignees were instructed to notify their customers immediately of this recall action, and direct them to discontinue distributing or dispensing the affected lots, plus return the affected products and lots to APP Pharmaceuticals, LLC in Bensenville, IL. Direct consignees with affected lots on hand were instructed to immediately discontinue distributing or dispensing the affected products and return them to APP Pharmaceuticals, LLC in Bensenville, IL 60106. Questions regarding the information on how to return product can be made to the firm's Quality Assurance Department at 1-866-716-2459. For questions regarding this recall call 847-969-2700.
- Initiated
- 2010-05-20
- Root cause
- Release of Material/Component prior to receiving test results
- Terminated
- 2012-06-20
- Distribution
- Nationwide Distribution and Puerto Rico
- Recall number
- Z-1825-2012
- Recall status
- Terminated
- CDRH record ID
- 109646
- FDA classified
- 2012-06-19
- Recall event number
- 57878